- Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
21-May-2019 WuXi STA and Dizal Pharmaceutical Sign CMC Development and Manufacturing Agreement WuXi STA
21-May-2019 UKI2S and Innovate UK launch new £10m initiative to accelerate growth of early stage science and engineering companies UKI2S
17-May-2019 Cleanroom industry experts join the Pharmaceutical Cleanroom Technology Conference in October SMi Group
17-May-2019 EMC Szpitale, Poland, brings access to innovative treatments to its patients by joining Clinerion’s Patient Network Explorer platform. Clinerion Ltd
16-May-2019 Medidata recognised as a 2019 UK Great Place to Work® Medidata
14-May-2019 As senior vice president of global operations, Sridhar will be responsible for integrating business units and provide operational excellence leadership across the Frontage organization Frontage
14-May-2019 New treatment could become first ever targeted therapy designed for ‘untreatable’ childhood brain cancer Transgene
14-May-2019 Transgene receives FDA IND Clearance for Lead myvac™ Individualized Immunotherapy, TG4050, to Commence Clinical Development in Ovarian Cancer Transgene
14-May-2019 Merck Announces Results from Phase 2 Trial of Investigational 15-valent Pneumococcal Conjugate Vaccine (V114) in Infants V114 Met Primary Endpoint by Demonstrating Noninferiority to PCV13 for all Shared Serotypes, and an Immune Response for Two Additional Serotypes Data Support Continued Progression of Phase 3 Studies with V114 MSD
14-May-2019 New registration for Tri-Solfen® expands commercial reach in New Zealand MSD
14-May-2019 SMC Accepts MSD’s KEYTRUDA®▼ (pembrolizumab) for Use Within NHS Scotland as Monotherapy for the Adjuvant Treatment of Adults with Stage III Melanoma with Lymph Node Involvement Who Have Undergone Complete Resection[i] MSD
14-May-2019 PureTech Health Affiliates Gelesis and Vedanta Biosciences Announce Presentations at Digestive Disease Week PureTech Health
14-May-2019 Poseida receives FDA orphan drug designation for lead candidate and FDA approval of fully outpatient dosing in Phase 2 clinical trial Poseida
14-May-2019 Kancera's research will be highlighted at this year's largest conference on cardiovascular diseases Kancera
14-May-2019 IFAD and the Philippines to invest $95.1 million in agribusiness development to increase incomes and reduce rural poverty IFAD
14-May-2019 Share Subscription and Issue of Equity Total Voting Rights Faron Pharmaceuticals
13-May-2019 Michel Mikhail invites Biosimilar experts to attend SMi’s 10th Annual Biosimilars Conference SMi Group
10-May-2019 Inpharamo will facilitate the entry of Clinerion into the Mexican clinical research market. Clinerion Ltd.
09-May-2019 New combination treatment for metastatic lung cancer patients approved for use on the NHS in England and Wales Roche